** Medical device maker Insulet's PODD.O shares rise 10.2% to $283.20 premarket
** Insulet late on Thursday beat Q1 profit estimates, buoyed by strong demand for its wearable insulin pumps
** Company earned $1.02 per share, above analysts' average estimate of 80 cents per share - data compiled by LSEG
** Company now expects its annual revenue to grow between 19% and 22%, compared with its previous projection of 16% to 20%
** Company's Q1 total revenue increased 28.8% to $569 million, compared with analysts' estimates of $543.4 million
** As of last close, stock down 1.6% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。